Urinary Tract Infection Tracked by Routine and Automated Urinalysis
|
By LabMedica International staff writers Posted on 13 Sep 2016 |

Image: The UF-1000i fully automated urine particle analyzer (Photo courtesy of Sysmex Corporation).
Urinary tract infections (UTIs) are frequently encountered and the diagnosis of UTI using urine dipstick, Gram stain, urine culture often lack proven accuracy and precision in the emergency department (ED).
Because of its swiftness and low cost, urine dipstick (UD) is a commonly used test at the ED, but diagnostic accuracy is, however, based on primary care settings and therefore not compatible with the ED. UTI is confirmed by results of urine cultures (UCs), which are labor intensive, time consuming, and not available within the time frame of an ED visit.
Scientists at the University Medical Center Groningen (The Netherlands) analyzed a total of 381 cases presenting with fever and/or clinically suspected UTI. The following specific symptoms for UTI were determined: dysuria, pollakisuria, urinary urgency, hematuria, and back pain/lower abdominal pain. In addition, specific symptoms of UTI were determined: fever, chills, malaise, flank or perineal pain, and delirium.
For Gram staining, 10 μL of uncentrifuged urine was used. The color (gram negative or gram positive); shape (rods or cocci); and number of leukocytes, erythrocytes, and bacteria per high-power field (hpf) were determined semi-quantitatively at 100 × 10 magnification. The automated stick reader cobas u 411 was used with the UD Combur10 test (Roche Diagnostics, Mannheim, Germany). For UC, 1 μL of urine was inoculated on two agars (sheep blood agar and MacConkey3 agar) and incubated at 35°C for 16-20 hours in ambient air. Isolated organisms were measured semi-quantitatively as number of colony-forming units (CFU) per milliliter. For automated urine particle analysis, the team used the Sysmex UF-1000i (Sysmex Corporation, Kobe, Japan) is a fully automated urine particle analyzer based on flow cytometry.
The scientists reported 143 (37.5%) cases were diagnosed with UTI. Sensitivity of urine dipstick nitrite was 32.9% and specificity was 93.7%. Sensitivity of urine dipstick leukocyte esterase (3+) was 80.4% and specificity was 82.8%. Of the 143 cases with a UTI, 91 had a noninvasive UTI, 16 had a urosepsis confirmed by blood culture, 24 had a urosepsis based on clinical presentation, 11 had a pyelonephritis, and one had a prostatitis. Receiver operating characteristic curves of automated bacterial and leukocyte count showed area under the curve of 0.851 and 0.872, respectively. Cutoff values of 133 bacteria/μL and 48 leukocytes/μL resulted in a greater than 90% sensitivity.
The authors concluded that that in an unselected patient group presenting to the ED with suspected UTI, automated urine particle analysis with counts of leukocytes and bacteria results in comparable diagnostic accuracy compared with standard dipstick analysis but can slightly improve diagnostic accuracy, especially to make UTI unlikely, when added to standard clinical and UD analysis. The study was published in the August 2016 issue of the American Journal of Emergency Medicine.
Related Links:
University Medical Center Groningen
Roche Diagnostics
Sysmex Corporation
Because of its swiftness and low cost, urine dipstick (UD) is a commonly used test at the ED, but diagnostic accuracy is, however, based on primary care settings and therefore not compatible with the ED. UTI is confirmed by results of urine cultures (UCs), which are labor intensive, time consuming, and not available within the time frame of an ED visit.
Scientists at the University Medical Center Groningen (The Netherlands) analyzed a total of 381 cases presenting with fever and/or clinically suspected UTI. The following specific symptoms for UTI were determined: dysuria, pollakisuria, urinary urgency, hematuria, and back pain/lower abdominal pain. In addition, specific symptoms of UTI were determined: fever, chills, malaise, flank or perineal pain, and delirium.
For Gram staining, 10 μL of uncentrifuged urine was used. The color (gram negative or gram positive); shape (rods or cocci); and number of leukocytes, erythrocytes, and bacteria per high-power field (hpf) were determined semi-quantitatively at 100 × 10 magnification. The automated stick reader cobas u 411 was used with the UD Combur10 test (Roche Diagnostics, Mannheim, Germany). For UC, 1 μL of urine was inoculated on two agars (sheep blood agar and MacConkey3 agar) and incubated at 35°C for 16-20 hours in ambient air. Isolated organisms were measured semi-quantitatively as number of colony-forming units (CFU) per milliliter. For automated urine particle analysis, the team used the Sysmex UF-1000i (Sysmex Corporation, Kobe, Japan) is a fully automated urine particle analyzer based on flow cytometry.
The scientists reported 143 (37.5%) cases were diagnosed with UTI. Sensitivity of urine dipstick nitrite was 32.9% and specificity was 93.7%. Sensitivity of urine dipstick leukocyte esterase (3+) was 80.4% and specificity was 82.8%. Of the 143 cases with a UTI, 91 had a noninvasive UTI, 16 had a urosepsis confirmed by blood culture, 24 had a urosepsis based on clinical presentation, 11 had a pyelonephritis, and one had a prostatitis. Receiver operating characteristic curves of automated bacterial and leukocyte count showed area under the curve of 0.851 and 0.872, respectively. Cutoff values of 133 bacteria/μL and 48 leukocytes/μL resulted in a greater than 90% sensitivity.
The authors concluded that that in an unselected patient group presenting to the ED with suspected UTI, automated urine particle analysis with counts of leukocytes and bacteria results in comparable diagnostic accuracy compared with standard dipstick analysis but can slightly improve diagnostic accuracy, especially to make UTI unlikely, when added to standard clinical and UD analysis. The study was published in the August 2016 issue of the American Journal of Emergency Medicine.
Related Links:
University Medical Center Groningen
Roche Diagnostics
Sysmex Corporation
Latest Microbiology News
- New Imaging Approach Could Help Predict Dangerous Gut Infection
- Rapid Sequencing Could Transform Tuberculosis Care
- Blood-Based Viral Signature Identified in Crohn’s Disease
- Hidden Gut Viruses Linked to Colorectal Cancer Risk
- Three-Test Panel Launched for Detection of Liver Fluke Infections
- Rapid Test Promises Faster Answers for Drug-Resistant Infections
- CRISPR-Based Technology Neutralizes Antibiotic-Resistant Bacteria
- Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
- AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
- New Test Measures How Effectively Antibiotics Kill Bacteria
- New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
- New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
- Breakthroughs in Microbial Analysis to Enhance Disease Prediction
- Blood-Based Diagnostic Method Could Identify Pediatric LRTIs
- Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
- Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
Channels
Molecular Diagnostics
view channel
Simple One-Hour Saliva Test Detects Common Cancers
Early detection is critical for improving cancer outcomes, yet many diagnostic tests rely on invasive procedures such as blood draws or biopsies. Researchers are exploring simpler approaches that could... Read more
Blood Test Could Help Guide Treatment Decisions in Germ Cell Tumors
Chemotherapy is often highly effective for germ cell tumors, but in a subset of patients, the disease does not respond well to standard treatment. For these individuals, doctors may consider high-dose... Read moreHematology
view channel
Rapid Cartridge-Based Test Aims to Expand Access to Hemoglobin Disorder Diagnosis
Sickle cell disease and beta thalassemia are hemoglobin disorders that often require referral to specialized laboratories for definitive diagnosis, delaying results for patients and clinicians.... Read more
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read moreImmunology
view channel
Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response
Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more
Immune Signature Identified in Treatment-Resistant Myasthenia Gravis
Myasthenia gravis is a rare autoimmune disorder in which immune attack at the neuromuscular junction causes fluctuating weakness that can impair vision, movement, speech, swallowing, and breathing.... Read more
New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer
Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read moreBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read moreMicrobiology
view channel
New Imaging Approach Could Help Predict Dangerous Gut Infection
Clostridioides difficile infections affect roughly half a million people in the United States each year and are a leading cause of infectious diarrhea in healthcare settings. The bacterium can trigger... Read more
Rapid Sequencing Could Transform Tuberculosis Care
Tuberculosis remains the world’s leading cause of death from a single infectious agent, responsible for more than one million deaths each year. Diagnosing and monitoring the disease can be slow because... Read morePathology
view channel
Novel mcPCR Technology to Transform Testing of Clinical Samples
DNA methylation is an important biological marker used in the diagnosis and monitoring of many diseases, including cancer. These chemical modifications to DNA influence gene activity and can reveal early... Read more
Sex Differences in Alzheimer’s Biomarkers Linked to Faster Cognitive Decline
Sex differences in Alzheimer’s disease present ongoing diagnostic challenges, with women often experiencing a disproportionate disease burden even when preclinical amyloid-beta levels are similar to men.... Read moreTechnology
view channel
AI Model Outperforms Clinicians in Rare Disease Detection
Rare diseases affect an estimated 300 million people worldwide, yet diagnosis is often protracted and error-prone. Many conditions present with heterogeneous signs that overlap with common disorders, leading... Read more
AI-Driven Diagnostic Demonstrates High Accuracy in Detecting Periprosthetic Joint Infection
Periprosthetic joint infection (PJI) is a rare but serious complication affecting 1% to 2% of primary joint replacement surgeries. The condition occurs when bacteria or fungi infect tissues around an implanted... Read moreIndustry
view channel
Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss
Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio
QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more







